Posted by Jay Halladay on Apr 26th, 2024
GeneDx (NASDAQ:WGS – Free Report) had its price objective boosted by BTIG Research from $11.00 to $15.00 in a research note published on Monday morning, Benzinga reports. They currently have a buy rating on the stock.
Separately,...
More of this article »